1. Guest, the 'News in Brief' for the week beginning 31st May 2021 is here.
    Dismiss Notice
  2. Welcome! To read the Core Purpose and Values of our forum, click here.
    Dismiss Notice
  3. Contribute to feedback on the CDC Evidence Review, for more details click here
    Dismiss Notice

Investigation of mast cell toll-like receptor 3 in CFS/ME & Systemic Mastocytosis using novel application of autoMACS..., 2017, Balinas et al

Discussion in 'BioMedical ME/CFS News' started by Andy, Dec 11, 2017.

  1. Andy

    Andy Committee Member (& Outreach when energy allows)

    Messages:
    13,216
    Likes Received:
    95,505
    Location:
    Hampshire, UK
    Full title - Investigation of mast cell toll-like receptor 3 in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis and Systemic Mastocytosis participants using the novel application of autoMACS magnetic separation and flow cytometry.
    https://www.ncbi.nlm.nih.gov/pubmed/29223146
     
    Andy, Dec 11, 2017
    #1
    Aroa, Barry, Indigophoton and 5 others like this.
  2. Snow Leopard

    Snow Leopard Senior Member (Voting Rights)

    Messages:
    2,861
    Likes Received:
    19,929
    Location:
    Australia
    Listing seems recent, DOI doesn't work yet.

    I don't understand how TLR3 ties into the results they've reported.
     
    Snow Leopard, Dec 11, 2017
    #2
    Barry, Inara, Esther12 and 2 others like this.
  3. Jonathan Edwards

    Jonathan Edwards Senior Member (Voting Rights)

    Messages:
    9,094
    Likes Received:
    97,205
    The abstract is confusing. It seems that they found evidence that PWME do not have systemic mastocytosis - which is not very surprising. There is no comment about the comparison between ME and controls.
     
    Jonathan Edwards, Dec 11, 2017
    #3
    TrixieStix, Aroa, Trish and 4 others like this.

Share This Page